SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-09-062178
Filing Date
2009-11-03
Accepted
2009-11-03 16:17:29
Documents
1
Group Members
WARBURG PINCUS & CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a09-32751_1sc13da.htm SC 13D/A 119679
  Complete submission text file 0001104659-09-062178.txt   121649
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81034 | Film No.: 091154696
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 466 LEXINGTON AVE. NEW YORK NY 10017 2128780600
WARBURG PINCUS EQUITY PARTNERS LP (Filed by) CIK: 0001075598 (see all company filings)

Type: SC 13D/A